No Data
No Data
RedHill Biopharma Finalizes Agreement to Bolster Finances
Express News | Redhill Biopharma Terminates Agreement With Movantik Acquisition, Valinor Pharma, And Hcr Redhill, And Received ~$9.9M In Cash And Gained Full Control Over An Additional $0.74M Currently Held In Restricted Account
RedHill Terminates License Agreement With Cosmo Technologies
RedHill Biopharma Terminates License Agreement For Aemcolo, A Treatment For Traveler's Diarrhea, Will Be Officially Terminated On October 8, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
RedHill Biopharma Has Received A Notice Of Allowance For Its U.S. Patent Application 17/900,235 Titled "BIOMARKERS OF CORONAVIRUS PNEUMONIA (FOR TREATING CORONAVIRUS INFECTION OR PREVENTING DISEASES CAUSED BY CORONAVIRUS INFECTION)"
No Data
EZ_money OP : Puuuuuuush